Investor Relations

Invest in Validated African Operating Infrastructure.

Six of our nine subsidiaries are already revenue-generating with zero enterprise churn — united under one cap table and disciplined group governance.

9
Active Co-Founders
$200k
Convertible Note
9
Operating Subsidiaries
₦72M
Gov. Engagement Pipeline
Investment Thesis

Why Partners Invest in A-Waves.

01

Verified Revenue First

Tech Suite Pro, Physio With Tolu, My Domiverse, Nourito, AfriStreet ID, and CrestGate Press already serve paying clients with 0% recurring churn.

02

Multi-Sector Resilience

Unlike single-product startups exposed to isolated shocks, A-Waves balances SaaS and publishing cashflow with healthcare and nutrition assets.

03

Proven Execution

Founded by an operator who closed ₦300M+ in enterprise contracts and built or operated 21 ventures across 9 years.

Current Round

$200k Convertible Note

● Open for Allocation
The Instrument
$200,000

Convertible Promissory Note ($1.5M Valuation Cap, 36-month maturity) deployed as working and expansion capital across our nine subsidiaries.

Minimum Ticket: $10,000
Use of Proceeds
SaaS, Marketplace & Publishing Scale45%
Clinical Research & Health Staffing30%
Food Production & Working Capital25%
Governed by Centralized Group Treasury
Partner Profile

Strategic & Institutional Partners

We partner with investors who bring African operational insight, institutional networks, or long-term capital alignment.

Request Term Sheet
Strategic Horizon

Three-Year Execution Roadmap

2026 — Year 101

Execution Phase

Revenue Target₦600M
ExecutionFull-time
Co-founders9 active
Team Size25 members
2027 — Year 202

Scale & Growth

Revenue Target₦900M
OperationsScaled
GrantsFirst institutional
Tech Suite Pro1,000 subscribers
2028 — Year 303

Consolidation

Revenue Target₦1.35B
StructureGroup consolidation
CAAHRADPeer-reviewed journal
CrestGate Press100+ titles published
FAQ

Common Investor Questions

A-Waves Holdings Ltd is the parent holding company registered in Nigeria, owning controlling equity stakes across all nine operating subsidiaries. Investors allocate at the holding level to capture diversified multi-sector upside.

We are raising $200,000 via a Convertible Promissory Note with a $1.5M Valuation Cap and 36-month maturity, serving as working and expansion capital across our revenue-generating subsidiaries.

45% is allocated to engineering & enterprise sales scale (Tech Suite Pro, My Domiverse, CrestGate Press), 30% to healthcare operations & clinical research (CAAHRAD, MedTech Staffing, Physio With Tolu), and 25% to consumer production, corporate working capital, and regulatory formalisation (Nourito, AfriStreet ID, A-Waves Consult).

Our 3-year trajectory targets ₦600M in Year 1, ₦900M in Year 2, and ₦1.35B in Year 3 group revenue, with structured dividend distribution beginning in Year 3 alongside Series A conversion.

Data Room Access

Request the Term Sheet & Financial Model.

Receive our 5-year financial model, subsidiary-by-subsidiary KPI breakdown, governance charter, and convertible note term sheet within 24 hours.

Convertible Note Term Sheet & Cap Table
9-Subsidiary P&L and KPI Breakdown
Group Treasury & Governance Charter
Direct 1-on-1 Founder Call
Request Investor Pack